Protocol for the trial to establish a causal linkage between mycotoxin exposure and child stunting: a cluster randomized trial

Erica Phillips, Francis Ngure, Laura E Smith, Edna Makule, Paul C Turner, Rebeca Nelson, Martin Kimanya, Rebecca Stoltzfus, Neema Kassim, Erica Phillips, Francis Ngure, Laura E Smith, Edna Makule, Paul C Turner, Rebeca Nelson, Martin Kimanya, Rebecca Stoltzfus, Neema Kassim

Abstract

Background: The number of stunted children has fallen globally but continues to increase in Africa. Stunting is estimated to contribute to 14-17% of child deaths under 5 years of age and is a risk factor for poor cognitive and motor development and educational outcomes. Inadequate dietary intake and disease are thought to be the immediate causes of undernutrition and stunting. However, improving infant diets through complementary feeding interventions has been shown to only modestly reduce stunting. Multiple observational studies demonstrate a dose response relationship between fetal and post-natal aflatoxin exposure and reduced linear growth.

Methods: This community-based cluster randomized trial will measure the effect of a reduced aflatoxin diet on length-for-age Z scores at 18 months in central Tanzania. All 52 health facilities in the Kongwa District of Dodoma Region were randomized into two groups. Starting at 6 months of age, participants in the intervention group receive a low-aflatoxin pre-blended porridge flour containing maize and groundnut (ratio 4:1 respectively) and low-aflatoxin groundnut flour, whereas in the control group the same porridge mix and groundnut flour are promoted through education but acquired by the household. Both groups will receive the same infant and young child feeding education and a thermos flask. A total of 3120 infants between 6 weeks and 3 months of age will be recruited into the study over 1 year. Data will be collected four times - at recruitment and when the infants are 6, 12 and 18 months of age. In a cohort of 600 infants, additional data will be collected at 9 and 15 months of age. The primary outcome is length-for-age at 18 months. Secondary outcomes include the Z scores for weight-for-age, middle upper arm circumference and head circumference, and the blood biomarker aflatoxin-albumin in the full sample, with the urine biomarker aflatoxin M1 analyzed in the cohort only.

Discussion: Better understanding the etiology of childhood stunting can lead to more appropriate interventions and policies to further reduce linear growth faltering and meet the Sustainable Development Goals.

Trial registration: NCT03940547, (April 24, 2019).

Keywords: Aflatoxin; Mycotoxin; Nutrition; Stunting.

Conflict of interest statement

The authors declare they have no competing interests.

References

    1. United Nations Children’s Fund (UNICEF), World Health Organization, International Bank for Reconstruction and Development/The World Bank . Levels and trends in child malnutrition: key findings of the 2019 Edition of the joint child malnutrition estimates. Geneva: World Health Organization; 2019.
    1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382(9890):427–451.
    1. Black RE, Bhutta ZA, et al. For the maternal and child Undernutrition group. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet. 2008;371:243–260.
    1. Walker SP, Wachs TD, Grantham-McGregor S, Black MM, Nelson CA, Huffman SL, et al. Inequality in early childhood: risk and protective factors for early child development. Lancet. 2011;378(9799):1325–1338.
    1. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B, et al. Developmental potential in the first 5 years for children in developing countries. Lancet. 2007;369(9555):60–70.
    1. Adair LS, Fall CH, Osmond C, Stein AD, Martorell R, Ramirez-Zea M, et al. Associations of linear growth and relative weight gain during early life with adult health and human capital in countries of low and middle income: findings from five birth cohort studies. Lancet. 2013;382(9891):525–534.
    1. UNICEF . Conceptual Framework of Undernutrition. 1990.
    1. Dewey KG, Adu-Afarwuah S. Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Matern Child Nutr. 2008;4(Suppl 1):24–85.
    1. Panjwani A, Heidkamp R. Complementary feeding interventions have a small but significant impact on linear and ponderal growth of children in low- and middle-income countries: a systematic review and meta-analysis. J Nutr. 2017;147(11):2169S–2178S.
    1. Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013;382(9890):452–477.
    1. Humphrey JH, Mbuya MNN, Ntozini R, Moulton LH, Stoltzfus RJ, Tavengwa NV, et al. Independent and combined effects of improved water, sanitation, and hygiene, and improved complementary feeding, on child stunting and anaemia in rural Zimbabwe: a cluster-randomised trial. Lancet Glob Health. 2019;7(1):e132–ee47.
    1. Null C, Stewart CP, Pickering AJ, Dentz HN, Arnold BF, Arnold CD, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Kenya: a cluster-randomised controlled trial. Lancet Glob Health. 2018;6(3):e316–ee29.
    1. Luby SP, Rahman M, Arnold BF, Unicomb L, Ashraf S, Winch PJ, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Bangladesh: a cluster randomised controlled trial. Lancet Glob Health. 2018;6(3):e302–ee15.
    1. Lassi ZS, Das JK, Zahid G, Imdad A, Bhutta ZA. Impact of education and provision of complementary feeding on growth and morbidity in children less than 2 years of age in developing countries: a systematic review. BMC Public Health. 2013;13(Suppl 3):S13.
    1. Smith LE, Stoltzfus RJ, Prendergast A. Food chain mycotoxin exposure, gut health, and impaired growth: a conceptual framework. Adv Nutr. 2012;3(4):526–531.
    1. Smith LE, Prendergast AJ, Turner PC, Mbuya MN, Mutasa K, Kembo G, et al. The potential role of Mycotoxins as a contributor to stunting in the SHINE trial. Clin Infect Dis. 2015;61(Suppl 7):S733–S737.
    1. Harper KM, Mutasa M, Prendergast AJ, Humphrey J, Manges AR. Environmental enteric dysfunction pathways and child stunting: a systematic review. PLoS Negl Trop Dis. 2018;12(1):e0006205.
    1. Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr. 2004;80(5):1106–1122.
    1. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans Volume 82. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. Lyon: International Agency for Research on Cancer; 2002.
    1. Wild CP, Miller DJ, Groopman JD. Mycotoxin control in low- and middle-income countries. Lyon: International Agency for Research on Cancer; 2015.
    1. Keusch GT, Rosenberg IH, Denno DM, Duggan C, Guerrant RL, Lavery JV, et al. Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food Nutr Bull. 2013;34(3):357–364.
    1. Mbuya MN, Humphrey JH. Preventing environmental enteric dysfunction through improved water, sanitation and hygiene: an opportunity for stunting reduction in developing countries. Matern Child Nutr. 2016;12(Suppl 1):106–120.
    1. Turner PC. The molecular epidemiology of chronic aflatoxin driven impaired child growth. Scientifica (Cairo) 2013;2013:152879.
    1. Hernandez-Vargas H, Castelino J, Silver MJ, Dominguez-Salas P, Cros MP, Durand G, et al. Exposure to aflatoxin B1 in utero is associated with DNA methylation in white blood cells of infants in the Gambia. Int J Epidemiol. 2015;44(4):1238–1248.
    1. Gong YY, Cardwell K, Hounsa A, Egal S, Turner PC, Hall AJ, et al. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. BMJ. 2002;325(7354):20–21.
    1. Gong Y, Hounsa A, Egal S, Turner PC, Sutcliffe AE, Hall AJ, et al. Postweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa. Environ Health Perspect. 2004;112(13):1334–1338.
    1. Turner PC, Collinson AC, Cheung YB, Gong Y, Hall AJ, Prentice AM, et al. Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int J Epidemiol. 2007;36(5):1119–1125.
    1. Shirima CP, Kimanya ME, Routledge MN, Srey C, Kinabo JL, Humpf HU, et al. A prospective study of growth and biomarkers of exposure to aflatoxin and fumonisin during early childhood in Tanzania. Environ Health Perspect. 2015;123(2):173–178.
    1. Mitchell NJ, Hsu HH, Chandyo RK, Shrestha B, Bodhidatta L, Tu YK, et al. Aflatoxin exposure during the first 36 months of life was not associated with impaired growth in Nepalese children: an extension of the MAL-ED study. PLoS One. 2017;12(2):e0172124.
    1. Hoffmann V, Jones K, Leroy J. Mitigating aflatoxin exposure to improve child growth in eastern Kenya: study protocol for a randomized controlled trial. Trials. 2015;16:552.
    1. Hoffmann V, Jones K, Leroy JL. The impact of reducing dietary aflatoxin exposure on child linear growth: a cluster randomised controlled trial in Kenya. BMJ Glob Health. 2018;3(6):e000983.
    1. Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDGEC) [Tanzania Mainland], Ministry of Health (MoH) [Zanzibar], National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICF. Tanzania Demographic and Health Survey and Malaria Indicator Survey (TDHS-MIS) 2015-16. Dar es Salaam Rockville: MoHCDGEC, MoH, NBS, OCGS, and ICF; 2016.
    1. Kongwa District Health Information Systems Office. Health information system. Kongwa; 2017–2018.
    1. Smith LE, Mbuya MNN, Prendergast AJ, Turner PC, Ruboko S, Humphrey JH, et al. Determinants of recent aflatoxin exposure among pregnant women in rural Zimbabwe. Mol Nutr Food Res. 2017;61(9).
    1. Gong YY, Egal S, Hounsa A, Turner PC, Hall AJ, Cardwell KF, et al. Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning. Int J Epidemiol. 2003;32(4):556–562.
    1. Dickin K, Griffiths M, Piwoz E. Designing by dialogue. A program planners’ guide to consultative research for improving young child feeding. Washington D.C: US Agency for International Development; 1997.
    1. Tanzanian Food and Nutrition Centre. Nutrition and health for the family. Dar Es Salaam; 2018.
    1. East African Standard Maize grains specification, HS 1005.90.00 (2011).
    1. Abbeddou S, Hess SY, Yakes Jimenez E, Some JW, Vosti SA, Guissou RM, et al. Comparison of methods to assess adherence to small-quantity lipid-based nutrient supplements (SQ-LNS) and dispersible tablets among young Burkinabe children participating in a community-based intervention trial. Matern Child Nutr. 2015;11(Suppl 4):90–104.
    1. Karakochuk C, van den Briel T, Stephens D, Zlotkin S. Food sharing practices in households receiving supplemental foods for the treatment of moderate acute malnutrition in Ethiopian children. J Hunger Environ Nutr. 2015;10(3):343–355.
    1. Cohuet S, Marquer C, Shepherd S, Captier V, Langendorf C, Ale F, et al. Intra-household use and acceptability of ready-to-use-supplementary-foods distributed in Niger between July and December 2010. Appetite. 2012;59(3):698–705.
    1. Groopman JD, Cain LG, Kensler TW. Aflatoxin exposure in human populations: measurements and relationship to cancer. Crit Rev Toxicol. 1988;19(2):113–145.
    1. Dusenbury L, Brannigan R, Falco M, Hansen WB. A review of research on fidelity of implementation: implications for drug abuse prevention in school settings. Health Educ Res. 2003;18(2):237–256.
    1. Victora CG, Habicht JP, Bryce J. Evidence-based public health: moving beyond randomized trials. Am J Public Health. 2004;94(3):400–405.
    1. Mbuya MN, Jones AD, Ntozini R, Humphrey JH, Moulton LH, Stoltzfus RJ, et al. Theory-driven process evaluation of the SHINE trial using a program impact pathway approach. Clin Infect Dis. 2015;61(Suppl 7):S752–S758.
    1. Kim SS, Habicht J-P, Menon P, Stoltzfus RJ. How do programs work to improve child nutrition? Program impact pathways of three nongovernmental organization intervention projects in the Peruvian highlands. Washington DC: IFPRI; 2011.
    1. Kim SS, Ali D, Kennedy A, Tesfaye R, Tadesse AW, Abrha TH, et al. Assessing implementation fidelity of a community-based infant and young child feeding intervention in Ethiopia identifies delivery challenges that limit reach to communities: a mixed-method process evaluation study. BMC Public Health. 2015;15:316.
    1. Rawat R, Nguyen PH, Ali D, Saha K, Alayon S, Kim SS, et al. Learning how programs achieve their impact: embedding theory-driven process evaluation and other program learning mechanisms in alive & thrive. Food Nutr Bull. 2013;34(3 Suppl):S212–S225.
    1. Ruel MT, Menon P, Habicht JP, Loechl C, Bergeron G, Pelto G, et al. Age-based preventive targeting of food assistance and behaviour change and communication for reduction of childhood undernutrition in Haiti: a cluster randomised trial. Lancet. 2008;371(9612):588–595.
    1. Christian P, Shaikh S, Shamim AA, Mehra S, Wu L, Mitra M, et al. Effect of fortified complementary food supplementation on child growth in rural Bangladesh: a cluster-randomized trial. Int J Epidemiol. 2015;44:1862–1876.
    1. Huybregts L, Houngbe F, Salpeteur C, Brown R, Roberfroid D, Ait-Aissa M, et al. The effect of adding ready-to-use supplementary food to a general food distribution on child nutritional status and morbidity: a cluster-randomized controlled trial. PLoS Med. 2012;9(9):e1001313.
    1. Katz J. Sample-size implications for population-based cluster surveys of nutritional status. Am J Clin Nutr. 1995;61(1):155–160.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera